Technology
Health
Biotechnology

Biocept

$2.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.78 (95.12%) Today
+$0.40 (25.00%) After Hours

Why Robinhood?

You can buy or sell Biocept and other stocks, options, ETFs, and crypto commission-free!

About

Biocept, Inc. Common Stock, also called Biocept, is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. Read More It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.

Employees
87
Headquarters
San Diego, California
Founded
1997
Market Cap
15.47M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.24M
High Today
$1.70
Low Today
$1.06
Open Price
$1.14
Volume
30.27M
52 Week High
$12.15
52 Week Low
$0.658

Collections

Technology
Health
Biotechnology
Medical
Advertising and Marketing
Biopharmaceutical
Business Services
Pharmaceutical

News

Benzinga15h

Mid-Day Market Update: Pinduoduo Falls After Q1 Results; Biocept Shares Jump

Midway through trading Monday, the Dow traded down 0.30 percent to 25,687.85 while the NASDAQ fell 1.23 percent to 7,720.10. The S&P also fell, dropping 0.43 percent to 2,847.15. Leading and Lagging Sectors Utilities shares rose by 0.6 percent on Monday. Meanwhile, top gainers in the sector included Spark Energy Inc (NASDAQ: SPKE), up 3 percent, and Just Energy Group Inc. (NYSE: JE), up 2 percent. In trading on Monday, information technology shares fell by 1.1 percent. Top Headline International Game T...

2,197
Benzinga16h

Cancer Diagnostic Company Biocept's Stock Doubles In Value: What You Need To Know

Shares of Biocept Inc (NASDAQ: BIOC), a molecular diagnostics company specializing in biomarker analysis of circulating tumor-associated DNA, are making a strong upward move Monday.

810
Seeking AlphaMay 8

Biocept, Inc. (BIOC) CEO Michael Nall on Q1 2019 Results - Earnings Call Transcript

Biocept, Inc. (NASDAQ:BIOC) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Kevin McCabe - LHA, Investor Relations Michael Nall - President and Chief Executive Officer Tim Kennedy - Senior Vice President of Operations and Chief Financial Officer Edwin Hendrick - Senior Vice President and Chief Commercial Officer Conference Call Participants Jason McCarthy - Maxim Group Operator Good day and welcome to the Biocept First Quarter Financial Results Conference Call. [Operato...

1,349

Earnings

-$3.30
-$2.23
-$1.16
-$0.09
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
-$0.61 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.